Hydrafacial Results Presentation Deck
Reconciliation of GAAP to non-GAAP measures (cont'd)
Reconciliation of net income to adjusted EBITDA
Three months ended June 30,
2023
$117.5
Unaudited ($in millions)
Net sales
Net income (loss)
Net income (loss) margin
Adjusted to exclude the following:
(Benefit) expense for income taxes
Depreciation expense
Amortization expense
Stock-based compensation expense
Interest expense
Interest income
Other (income) expense, net
Change in fair value of warrant liability
Foreign currency (gain) loss, net
Loss on disposal of assets
Transaction related costs
Write-off of discontinued and obsolete product
Litigation related costs
Syndeo product optimization logistics & service costs
Accrual for annual cash incentives²
Severance, restructuring and other
Adjusted EBITDA
Adjusted EBITDA margin
41
Note: Amounts may not sum due to rounding.
Reflects the impact of immaterial revisions to the financial statements.
Amount in the prior period adjusted for comparability purposes.
1.
2.
$3.4
2.9%
(2.2)
2.6
7.8
8.5
3.4
(5.7)
(0.0)
(11.6)
(0.4)
0.8
1.0
0.5
1.4
5.4
2.8
$17.8
15.1%
2022¹
$103.5
$6.3
6.1%
0.1
1.9
3.9
6.4
3.2
(0.7)
(0.9)
(15.2)
2.2
1.0
2.0
3.6
0.9
$14.6
14.1%
Six months ended June 30,
2023
$203.8
($16.9)
(8.3%)
(5.9)
4.5
12.2
12.1
6.8
(10.0)
(0.5)
(2.5)
(1.5)
0.1
0.8
4.0
1.5
1.4
5.4
5.7
$17.3
8.5%
2022¹
$179.0
$37.8
21.1%
2.7
3.3
7.7
13.4
6.6
(0.7)
0.0
(67.2)
1.8
1.0
3.0
6.1
2.9
$18.3
10.2%
BEAUTYHEALTH™View entire presentation